Boston Scientific Corporation,a global medical technology leader, has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company that develops, manufactures and ...

Acute cholecystitis, an inflammation of the gallbladder usually due to obstructing gallstones, is conventionally managed by early cholecystectomy. In patients unfit for surgery owing to comorbidities ...

The objective of this study was to compare the diagnostic efficacy and safety of ultrasound-guided percutaneous transhepatic gallbladder biopsy (PTGB) with endoscopic ultrasound-guided fine-needle ...

The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from ...